Literature DB >> 11380259

Increase in the stability and helical content of estrogen receptor alpha in the presence of the estrogen response element: analysis by circular dichroism spectroscopy.

N Greenfield1, V Vijayanathan, T J Thomas, M A Gallo, T Thomas.   

Abstract

Ligand-dependent stabilization of the estrogen receptor (ER) is often postulated, with limited support from experimental data. We studied the thermal unfolding of recombinant ERalpha by circular dichroism (CD) spectroscopy. The T(M) of unfolding of ERalpha was 38 +/- 2.4 degrees C, and the van't Hoff enthalpy of unfolding was 31.7 +/- 3.4 kcal/mol in the absence of ligands. Addition of estradiol (E(2)) increased the T(M) to 43.6 +/- 2.3 degrees C, while addition of E(2) and an oligonucleotide harboring the estrogen response element (ERE) increased the T(M) to 47.9 +/- 1.6 degrees C. Addition of the antiestrogen 4-hydroxytamoxifen (HT) alone did not increase the T(M); however, a combination of HT and the ERE increased the T(M) to 48.9 +/- 1.0 degrees C. The ERE alone increased the T(M) to 46.1 +/- 0.9 degrees C. Addition of E(2) alone had no effect on the apparent enthalpy of unfolding; however, the ERE alone increased the apparent enthalpy from 31.7 to 36.1 kcal/mol. ERalpha samples containing the ERE also exhibited an increase in the negative ellipticity at 208 and 222 nm, relative to that of ligand-free ERalpha, suggesting a stabilization of the alpha-helix. CD data analysis further showed that the presence of the ERE caused a large increase in alpha-helical content of ERalpha in both the presence and absence of the ligands. This increase in alpha-helical content of ERalpha was not observed in the presence of a nonspecific oligonucleotide. These results show that the ERE can increase the thermal stability of ERalpha, enhance its alpha-helical content, and facilitate the cooperativity of the folding transition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380259     DOI: 10.1021/bi002846l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

2.  Understanding ligand binding effects on the conformation of estrogen receptor alpha-DNA complexes: a combinational quartz crystal microbalance with dissipation and surface plasmon resonance study.

Authors:  Wendy Y X Peh; Erik Reimhult; Huey Fang Teh; Jane S Thomsen; Xiaodi Su
Journal:  Biophys J       Date:  2007-03-23       Impact factor: 4.033

3.  TraA and its N-terminal relaxase domain of the Gram-positive plasmid pIP501 show specific oriT binding and behave as dimers in solution.

Authors:  Jolanta Kopec; Alexander Bergmann; Gerhard Fritz; Elisabeth Grohmann; Walter Keller
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

4.  Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1.

Authors:  Marion Desclozeaux; Irina N Krylova; Florence Horn; Robert J Fletterick; Holly A Ingraham
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

5.  Formation of an hER alpha-COUP-TFI complex enhances hER alpha AF-1 through Ser118 phosphorylation by MAPK.

Authors:  Raphaël Métivier; Frédérique A Gay; Michael R Hübner; Gilles Flouriot; Gilles Salbert; Frank Gannon; Olivier Kah; Farzad Pakdel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

6.  Characterization of multiple stable conformers of the EC5 domain of E-cadherin and the interaction of EC5 with E-cadherin peptides.

Authors:  Kai Zheng; Jennifer S Laurence; Krzysztof Kuczera; Gennady Verkhivker; C Russell Middaugh; Teruna J Siahaan
Journal:  Chem Biol Drug Des       Date:  2009-06       Impact factor: 2.817

7.  Identification and characterization of a novel chemotype MEK inhibitor able to alter the phosphorylation state of MEK1/2.

Authors:  Takayuki Yoshida; Junya Kakegawa; Takayuki Yamaguchi; Yoshiji Hantani; Nobuyuki Okajima; Toshiyuki Sakai; Yoshihiro Watanabe; Motonao Nakamura
Journal:  Oncotarget       Date:  2012-12

8.  Rational modification of estrogen receptor by combination of computational and experimental analysis.

Authors:  Valentina Elisabetta Viviana Ferrero; Mattia Pedotti; Alessandro Chiadò; Luca Simonelli; Luigi Calzolai; Luca Varani; Teresa Lettieri
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.